Immunic

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.

About IMUX

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.

CEO

Daniel Vitt

CEODaniel Vitt

Employees

Employees91

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2003

Founded2003

Employees

Employees91

IMUX Key Statistics

Market cap

75.52M

Market cap75.52M

Price-Earnings ratio

-0.82

Price-Earnings ratio-0.82

Dividend yield

—

Dividend yield—

Average volume

1.57M

Average volume1.57M

High today

$0.83

High today$0.83

Low today

$0.752

Low today$0.752

Open price

$0.8028

Open price$0.8028

Volume

1.40M

Volume1.40M

52 Week high

$2.11

52 Week high$2.11

52 Week low

$0.561

52 Week low$0.561

IMUX News

TipRanks 6d

Immunic receives notice of allowance for vidofludimus calcium patent

Immunic (IMUX) announced that it has received a notice of allowance from the United States Patent and Trademark Office for patent application 18/529,946, entitl...

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.